Appendix 4E and FY26 financial reports
Filed with ASX · · 117 pages · English
Summary by 6ix AI
The report highlights a slight decrease in total revenue compared to the previous year, alongside a notable decline in statutory profit attributable to members. The company declared a final fully franked dividend, reflecting its commitment to returning value to shareholders.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Australian Clinical Labs Ltd on 6ix
Earlier from Australian Clinical Labs
- Appointment of new Group CEO
- Class action proceedings
- CEO contract update
- Appendix 4D and 1H26 financial reports
- ACL 1H26 financial results investor presentation
Follow Australian Clinical Labs into a list and get an email when it puts out news.
Follow Australian Clinical Labs